Cargando…
Clinical pharmacology of cytotoxic drugs in neonates and infants: Providing evidence-based dosing guidance
Cancer in neonates and infants is a rare but challenging entity. Treatment is complicated by marked physiological changes during the first year of life, excess rates of toxicity, mortality, and late effects. Dose optimisation of chemotherapeutics may be an important step to improving outcomes. Body...
Autores principales: | Nijstad, A. Laura, Barnett, Shelby, Lalmohamed, Arief, Bérénos, Inez M., Parke, Elizabeth, Carruthers, Vickyanne, Tweddle, Deborah A., Kong, Jordon, Zwaan, C. Michel, Huitema, Alwin D.R., Veal, Gareth J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8914347/ https://www.ncbi.nlm.nih.gov/pubmed/34865945 http://dx.doi.org/10.1016/j.ejca.2021.11.001 |
Ejemplares similares
-
A Population Pharmacokinetic Modelling Approach to Unravel the Complex Pharmacokinetics of Vincristine in Children
por: Nijstad, A. Laura, et al.
Publicado: (2022) -
Vincristine dosing, drug exposure and therapeutic drug monitoring in neonate and infant cancer patients
por: Barnett, Shelby, et al.
Publicado: (2022) -
Generation of evidence-based carboplatin dosing guidelines for neonates and infants
por: Barnett, Shelby, et al.
Publicado: (2023) -
Overestimation of the effect of (fos)aprepitant on intravenous dexamethasone pharmacokinetics requires adaptation of the guidelines for children with chemotherapy-induced nausea and vomiting
por: Nijstad, A. Laura, et al.
Publicado: (2022) -
A semi‐mechanistic model based on glutathione depletion to describe intra‐individual reduction in busulfan clearance
por: Langenhorst, Jurgen B., et al.
Publicado: (2020)